Pneumonia is a major cause of death among patients with heart failure (HF), and improved risk prediction could enable earlier escalation of care and more proactive clinical management. However, robust prediction tools using routinely collected electronic health record (EHR) data for this HF population remain limi...
Y. Qi, Q. Ren, A. Mastumoto et al.· European Heart Journal· 0 citations
Abstract Background The nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease (MASLD) better encapsulates the associated metabolic milieu. While MASLD is associated with increased heart failure (HF) risk, characteristics and outcomes of MASLD in patients...
N. Chew, Chandramouli Chanchal, W. Tay et al.· Open Heart· 0 citations
Patients with concurrent heart failure (HF) and type 2 diabetes mellitus (T2DM) have a markedly elevated cancer risk, yet the optimal glycemic control target for reducing oncologic risk in this population is unclear. Nonlinear relationships between glycemic markers and cancer outcomes have been suggested, but thi...
Y. Qi, Q. Ren, A. Mastumoto et al.· European Heart Journal· 0 citations
MolADR is proposed, a multiscale complementary learning framework that integrates GNN-based KG learning with dual-granularity molecular cross-attention modeling to combine macro-level biomedical associations with microlevel molecular interaction cues, suggesting its ability to highlight chemically plausible atoms and f...
Yi-Fan Qi, Qing-Wen Ren, Chen-Xu Wang et al.· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.